Biotech Values

[drbio45]

you have a refractory population of schizophrenia that hasn't been helped by any drugs.

I am not in repligen right now but that doesn't mean secretin won't be a benefit to some people.

In the high dose cohort 4 of 14 people showed a much improved or very much improved reaction, which is double the response for the placebo, which was 2 of 15.

I don't think there is much of a market but I hope it works out. These trials weren't powered to show statistical significance